AIkido Pharma Inc.

NASDAQ: AIKI · Real-Time Price · USD
3.56
0.03 (0.85%)
At close: Dec 22, 2022, 6:00 AM

AIkido Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Revenue
18.15M n/a n/a
Cost of Revenue
n/a n/a n/a
Gross Profit
n/a n/a n/a
Operating Income
-11.53M -14.35M -9.44M
Interest Income
960K 687K 252K
Pretax Income
-14.7M -22.11M -7.17M
Net Income
-14.7M -29.87M -4.9M
Selling & General & Admin
29.67M 11.68M 7.73M
Research & Development
n/a 830K 559K
Other Expenses
n/a 1.83M 1.15M
Operating Expenses
29.67M 14.35M 9.44M
Interest Expense
n/a 7.76M -2.27M
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
n/a 14.35M 9.44M
Income Tax Expense
n/a 7.76M -2.27M
Shares Outstanding (Basic)
6.18M 5.33M 5.27M
Shares Outstanding (Diluted)
6.18M 5.33M 5.27M
EPS (Basic)
-2.38 -5.6 -0.93
EPS (Diluted)
-2.38 -5.6 -0.93
EBITDA
-11.53M -14.35M -7.17M
EBIT
n/a n/a -9.44M
Depreciation & Amortization
n/a -188K 2.27M